Arphra/Issuer/VRDN

VRDN

Viridian Therapeutics, Inc.

HealthcareBiotechnologyUSUSD

$16.96

LiveJun 01, 2026

AI Brief

Market cap

$1.53B

52w range

13.18 – 34.29

P / E

—

EPS

—

Volume

1.28M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Viridian Therapeutics, Inc.’s valuation

Total filings

Last ~200

YTD

2026

8-Ks · 12mo

Current reports

Last filing

—

AI · Disclosure analysis

Arphra AI

Click Analyze filings to have Arphra AI review the last 80 SEC filings for VRDN and return: a one-paragraph summary of recent disclosure activity, 3-5 thematic patterns, 3-5 notable individual filings worth flagging, and 2-3 watch items.

M&A activity

1DB

Whole-company transactions where VRDN is acquirer or target.

Date	Role	Counterparty	Filing
Dec 02, 2016	Acquirer	Miragen	SEC →

No filings in last 5 years.

Form-type mix

No data.

All 8-K · Current reports 10-K · 10-Q Proxy & ownership Registration Other

0 filingsDB · sec_filings

Filed	Accepted	Form	Description	Link
No filings in this group.